CLU and Alzheimer disease: When crossed with clusterin null mice, PDAPP AD model mice (which express the human APP mutant V717F at ten times the level of endogenous APP) show reduced levels of neuritic dystrophy and fibrillary amyloid plaques within the brain, without an overall change in levels of Abeta (DeMattos et al., 2002).